Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06).

---

Autoria(s): Ruhstaller T.; Pless M.; Dietrich D.; Kranzbuehler H.; von Moos R.; Moosmann P.; Montemurro M.; Schneider P.M.; Rauch D.; Gautschi O.; Mingrone W.; Widmer L.; Inauen R.; Brauchli P.; Hess V.

Data(s)	2011
Identificador	http://serval.unil.ch/?id=serval:BIB_7276CBC14AD3 isbn:1527-7755 (Electronic) pmid:21205757 doi:10.1200/JCO.2010.31.9715 isiid:000287444000018
Idioma(s)	en
Fonte	Journal of Clinical Oncology, vol. 29, no. 6, pp. 626-631
Palavras-Chave	#Adenocarcinoma/drug therapy; Adenocarcinoma/radiotherapy; Aged; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal/adverse effects; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Squamous Cell/drug therapy; Carcinoma, Squamous Cell/radiotherapy; Cisplatin/administration & dosage; Cisplatin/adverse effects; Digestive System Surgical Procedures; Esophageal Neoplasms/drug therapy; Esophageal Neoplasms/radiotherapy; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Multicenter Studies as Topic; Neoadjuvant Therapy/methods; Taxoids/administration & dosage; Taxoids/adverse effects
Tipo	info:eu-repo/semantics/article article